Clinical Trial Update: A Study to Assess Change in Disease Activity in Adolescents and Adults With Moderate to Severe Prurigo-type Atopic Dermatitis in Japan Who Are Treated With Oral Upadacitinib

View source ↗

Summary

A completed clinical trial evaluating change in disease activity in adolescents and adults with moderate-to-severe prurigo-type atopic dermatitis in Japan treat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Upadacitinib (upadacitinib)

Snippet

Sponsor: AbbVie | Conditions: Atopic Dermatitis | Status: COMPLETED